H
HaTay Pharmaceutical JSC
VN:DHT
HaTay Pharmaceutical JSC
VN:DHT
Price:
95 700
VND
0.84%
Market Closed
Market Cap:
7.9T
VND
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
DHT Alert
HaTay Pharmaceutical JSC
95700
+800 (+0.84%)
| 52 Week Range |
22 800
108 300
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
HaTay Pharmaceutical JSC
Cash Flow Statement
Cash Flow Statement
HaTay Pharmaceutical JSC
HaTay Pharmaceutical JSC
Currency: VND
| Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Sep-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
| Cash Taxes Paid |
(10 024)
|
(10 394)
|
(7 010)
|
(11 149)
|
(7 869)
|
(17 420)
|
(1 417)
|
(3 646)
|
5 803
|
(12 314)
|
(14 731)
|
(15 873)
|
(22 709)
|
(19 926)
|
(18 646)
|
(20 676)
|
(21 140)
|
(22 076)
|
0
|
(21 210)
|
0
|
(21 716)
|
0
|
(34 183)
|
0
|
(24 547)
|
(40 798)
|
(33 532)
|
(38 497)
|
(16 423)
|
(18 089)
|
(17 600)
|
(17 799)
|
(21 049)
|
(24 361)
|
(26 137)
|
(27 415)
|
(26 106)
|
(21 281)
|
(18 480)
|
(16 952)
|
|
| Cash Interest Paid |
(17 355)
|
(8 123)
|
(9 003)
|
(8 505)
|
(317)
|
(12 070)
|
(460)
|
(2 913)
|
3 809
|
(8 835)
|
(8 758)
|
(9 036)
|
(13 812)
|
(10 517)
|
(11 169)
|
(11 800)
|
(12 515)
|
(12 924)
|
0
|
(14 133)
|
0
|
(14 832)
|
0
|
(20 858)
|
0
|
(13 369)
|
(22 349)
|
(19 870)
|
(23 334)
|
(13 953)
|
(14 836)
|
(14 584)
|
(14 400)
|
(14 350)
|
(15 702)
|
(18 500)
|
(21 570)
|
(20 100)
|
(18 494)
|
(15 313)
|
(12 064)
|
|
| Change in Working Capital |
32 097
|
3 149
|
36 040
|
25 260
|
18 738
|
99 012
|
10 641
|
72 424
|
(51 984)
|
66 578
|
62 359
|
44 583
|
101 347
|
33 406
|
25 718
|
48 094
|
63 719
|
126 656
|
0
|
147 736
|
0
|
143 698
|
0
|
215 643
|
0
|
132 607
|
228 139
|
145 249
|
65 943
|
7 083
|
(47 005)
|
(57 671)
|
42 881
|
(4 072)
|
105 632
|
108 560
|
196 228
|
317 005
|
337 885
|
325 844
|
283 351
|
|
| Cash from Operating Activities |
85 894
N/A
|
(15 367)
N/A
|
21 394
N/A
|
5 607
-74%
|
(51 901)
N/A
|
13 137
N/A
|
29 021
+121%
|
44 806
+54%
|
17 977
-60%
|
45 429
+153%
|
43 595
-4%
|
19 673
-55%
|
4 477
-77%
|
2 964
-34%
|
(5 607)
N/A
|
15 620
N/A
|
30 065
+92%
|
91 655
+205%
|
0
N/A
|
112 393
N/A
|
0
N/A
|
107 150
N/A
|
0
N/A
|
160 602
N/A
|
0
N/A
|
94 692
N/A
|
164 992
+74%
|
91 848
-44%
|
116 871
+27%
|
(23 293)
N/A
|
(79 930)
-243%
|
(89 856)
-12%
|
(102 079)
-14%
|
(39 471)
+61%
|
65 569
N/A
|
63 922
-3%
|
147 243
+130%
|
270 799
+84%
|
298 110
+10%
|
292 052
-2%
|
254 335
-13%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
| Capital Expenditures |
(13 186)
|
(7 410)
|
(6 435)
|
(9 972)
|
(2 860)
|
(18 174)
|
0
|
(14 705)
|
(1 274)
|
(10 485)
|
(19 627)
|
(19 706)
|
(25 366)
|
(18 607)
|
(9 551)
|
(3 336)
|
(15 362)
|
(20 587)
|
0
|
(45 171)
|
0
|
(40 293)
|
0
|
(57 689)
|
0
|
(89 016)
|
(143 146)
|
(151 044)
|
(175 031)
|
(60 524)
|
(30 879)
|
(39 571)
|
(90 833)
|
(246 553)
|
(401 846)
|
(353 751)
|
(328 817)
|
(366 523)
|
(307 339)
|
(287 062)
|
(345 665)
|
|
| Other Items |
(13 579)
|
9 099
|
(1 114)
|
(3 123)
|
10 086
|
(5 490)
|
4 973
|
741
|
625
|
878
|
358
|
1 503
|
(178)
|
114
|
333
|
8 265
|
8 370
|
(16 169)
|
0
|
3 342
|
0
|
22 041
|
0
|
8 217
|
0
|
2 425
|
(362 848)
|
(347 493)
|
(346 116)
|
(349 649)
|
107 397
|
222 333
|
274 283
|
323 352
|
221 856
|
104 648
|
27 146
|
(43 092)
|
(99 636)
|
(83 554)
|
(46 349)
|
|
| Cash from Investing Activities |
(26 765)
N/A
|
1 688
N/A
|
(7 548)
N/A
|
(13 095)
-73%
|
7 225
N/A
|
(23 665)
N/A
|
5 503
N/A
|
(5 143)
N/A
|
8 171
N/A
|
(9 607)
N/A
|
(19 269)
-101%
|
(18 202)
+6%
|
(25 544)
-40%
|
(18 493)
+28%
|
(9 218)
+50%
|
4 928
N/A
|
(6 992)
N/A
|
(36 756)
-426%
|
0
N/A
|
(41 829)
N/A
|
0
N/A
|
(18 251)
N/A
|
0
N/A
|
(49 472)
N/A
|
0
N/A
|
(86 591)
N/A
|
(505 994)
-484%
|
(498 537)
+1%
|
(521 147)
-5%
|
(410 174)
+21%
|
76 518
N/A
|
182 762
+139%
|
183 450
+0%
|
76 799
-58%
|
(179 990)
N/A
|
(249 103)
-38%
|
(301 671)
-21%
|
(409 615)
-36%
|
(406 975)
+1%
|
(370 616)
+9%
|
(392 015)
-6%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
367 749
|
367 749
|
367 749
|
367 749
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
180 600
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(37 484)
|
17 062
|
16 179
|
28 637
|
47 328
|
18 500
|
0
|
(278)
|
(21 204)
|
12 728
|
(1 212)
|
12 578
|
80 234
|
58 865
|
44 123
|
57 413
|
17 886
|
(32 330)
|
0
|
(46 713)
|
0
|
(33 180)
|
0
|
(4 240)
|
0
|
42 030
|
91 673
|
100 286
|
129 430
|
85 247
|
58 766
|
(30 711)
|
(44 232)
|
47 414
|
110 508
|
193 321
|
164 268
|
166 857
|
114 997
|
(48 777)
|
8 884
|
|
| Cash Paid for Dividends |
0
|
202
|
0
|
(24 694)
|
(24 694)
|
(25 570)
|
(6 180)
|
(9 462)
|
7 056
|
(21 469)
|
(21 469)
|
(15 058)
|
(37 083)
|
(15 483)
|
(28 045)
|
(45 639)
|
(33 076)
|
(51 353)
|
0
|
(21 197)
|
0
|
(46 823)
|
0
|
(89 578)
|
0
|
(44 382)
|
(107 496)
|
(64 741)
|
(65 943)
|
(20 359)
|
(26 407)
|
(25 644)
|
(29 326)
|
(51 288)
|
(24 880)
|
(25 643)
|
(22 820)
|
0
|
(47 350)
|
(41 170)
|
(39 110)
|
|
| Cash from Financing Activities |
(37 484)
N/A
|
17 264
N/A
|
16 179
-6%
|
3 943
-76%
|
22 634
+474%
|
(7 070)
N/A
|
(6 180)
+13%
|
(9 740)
-58%
|
(14 148)
-45%
|
(8 741)
+38%
|
(22 681)
-159%
|
(2 480)
+89%
|
43 152
N/A
|
43 382
+1%
|
16 077
-63%
|
11 774
-27%
|
(15 191)
N/A
|
(83 683)
-451%
|
0
N/A
|
(67 910)
N/A
|
0
N/A
|
(80 003)
N/A
|
0
N/A
|
(93 818)
N/A
|
0
N/A
|
(2 352)
N/A
|
351 926
N/A
|
403 293
+15%
|
431 236
+7%
|
432 637
+0%
|
32 359
-93%
|
(56 356)
N/A
|
(73 558)
-31%
|
(3 873)
+95%
|
85 627
N/A
|
167 678
+96%
|
141 447
-16%
|
347 457
+146%
|
248 246
-29%
|
90 653
-63%
|
150 373
+66%
|
|
| Change in Cash | ||||||||||||||||||||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(4)
|
0
|
0
|
2
|
0
|
2
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
(3)
|
0
|
0
|
(3)
|
7
|
0
|
(3)
|
0
|
4
|
0
|
2
|
0
|
3
|
2
|
14
|
3
|
5
|
5
|
0
|
0
|
9
|
15
|
18
|
0
|
18
|
0
|
19
|
0
|
|
| Net Change in Cash |
21 641
N/A
|
3 585
-83%
|
30 025
+738%
|
(3 543)
N/A
|
(22 042)
-522%
|
(17 596)
+20%
|
28 344
N/A
|
29 923
+6%
|
12 000
-60%
|
27 084
+126%
|
1 645
-94%
|
(1 009)
N/A
|
22 085
N/A
|
27 850
+26%
|
1 252
-96%
|
32 322
+2 482%
|
7 880
-76%
|
(28 778)
N/A
|
0
N/A
|
2 651
N/A
|
0
N/A
|
8 899
N/A
|
0
N/A
|
17 313
N/A
|
0
N/A
|
5 752
N/A
|
10 925
+90%
|
(3 382)
N/A
|
26 965
N/A
|
(825)
N/A
|
28 952
N/A
|
36 551
+26%
|
7 814
-79%
|
33 463
+328%
|
(28 779)
N/A
|
(17 485)
+39%
|
(12 981)
+26%
|
208 658
N/A
|
139 381
-33%
|
12 107
-91%
|
12 694
+5%
|
|
| Free Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
| Free Cash Flow |
72 708
N/A
|
(22 777)
N/A
|
14 959
N/A
|
(4 365)
N/A
|
(54 761)
-1 154%
|
(5 037)
+91%
|
29 021
N/A
|
30 101
+4%
|
16 703
-45%
|
34 944
+109%
|
23 968
-31%
|
(33)
N/A
|
(20 889)
-63 200%
|
(15 643)
+25%
|
(15 158)
+3%
|
12 284
N/A
|
14 703
+20%
|
71 068
+383%
|
0
N/A
|
67 222
N/A
|
0
N/A
|
66 858
N/A
|
0
N/A
|
102 912
N/A
|
0
N/A
|
5 676
N/A
|
21 846
+285%
|
(59 196)
N/A
|
(58 159)
+2%
|
(83 817)
-44%
|
(110 808)
-32%
|
(129 427)
-17%
|
(192 912)
-49%
|
(286 024)
-48%
|
(336 277)
-18%
|
(289 829)
+14%
|
(181 574)
+37%
|
(95 725)
+47%
|
(9 228)
+90%
|
4 989
N/A
|
(91 330)
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
